MMP9 and pituitary gland adenoma: SPD304, as a small‐molecule inhibitor of TNFα, can inhibit the upregulation of TNFα on MAPK and MMP9, thereby reducing the membrane invasion capability and bone invasion ability of pituitary adenoma cells.